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Abstract
Infection with Bartonella spp may cause cardiac arrhythmias, myocarditis and endocarditis in humans. The aim of the present 
study was to evaluate a possible association between Bartonella spp bacteremia and endocarditis, arrhythmia and Chagas 
cardiomyopathy in patients from Brazil and Argentina. We screened for the presence of bacterial 16S rRNA in human blood 
by PCR using oligonucleotides to amplify a 185-bp bacterial DNA fragment. Blood samples were taken from four groups of 
subjects in Brazil and Argentina: i) control patients without clinical disease, ii) patients with negative blood-culture endocarditis, 
iii) patients with arrhythmias, and iv) patients with chronic Chagas cardiomyopathy. PCR products were analyzed on 1.5% 
agarose gel to visualize the 185-bp fragment and then sequenced to confirm the identity of DNA. Sixty of 148 patients (40.5%) 
with cardiac disease and 1 of 56 subjects (1.8%) from the control group presented positive PCR amplification for Bartonella 
spp, suggesting a positive association of the bacteria with these diseases. Separate analysis of the four groups showed that 
the risk of a Brazilian patient with endocarditis being infected with Bartonella was 22 times higher than in the controls. In ar-
rhythmic patients, the prevalence of infection was 45 times higher when compared to the same controls and 40 times higher 
for patients with Chagas cardiomyopathy. To the best of our knowledge this is the first report of the association between 
Bartonella spp bacteremia and Chagas disease. The present data may be useful for epidemiological and prevention studies 
in Brazil and Argentina.
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The Gram-negative organisms of the Bartonella genus 
are fastidious micro-aerobic bacteria classified into the 
second subgroup of the Proteobacteria class (1). This ge-
nus contains about 30 species, some of which have been 
isolated from humans (B. bacilliformis, B. henselae, B. 
elizabethae, and B. quintana) and from cats and dogs (B. 
koehlerae and B. vinsonii berkhoffii). Most known species 
of Bartonella have been isolated from rodent blood (2,3).
The life cycle of Bartonella spp consists of a reservoir 
host and vectors (e.g., ticks, fleas and lice) that transmit 
bacteria from the reservoir to novel hosts (3). Transmission 
may also occur through shared needles and syringes used 
by drug users. Hosts accidentally infected with Bartonella 
spp can show systemic signs, such as bacteremia and 
cardiac diseases mostly related to abnormalities in the heart 
valves, which may result in endocarditis (4,5). Surgery may 
be required in 20-40% of patients with infective endocarditis, 
mostly for valve replacement (5,6).
Ticks are considered to be zoonotic vectors that cause 
several diseases, and the tick Ixodes pacificus in particular 
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may play an important role in the transmission of Bartonella 
to both humans and animals (2). Bartonella has been found 
in the blood of residential animals (domestic cats and dogs) 
and rodents, which are regarded as vectors and transmitters 
of several diseases (7,8). B. v. berkhoffii was isolated from a 
domestic dog with endocarditis (9), and an epidemiological 
study demonstrated that B. v. berkhoffii infection frequently 
occurs through ticks (10). B. v. berkhoffii and B. henselae were 
isolated from cerebrospinal fluid and periodontal swab samples 
from a patient who had contact with infected animals (11).
B. bacilliformis has also been found in erythrocytes, resulting 
in a severe hemolytic anemia known as Oroya fever (12). The 
cat-scratch disease, which is mainly caused by B. henselae, 
has been described as the most common Bartonella infection 
in humans worldwide (13). B. quintana infection was described 
during World War I, leading to trench or quintana fever (13), 
and there have been recent reports of urban trench fever 
(14,15). The symptoms of Bartonella infection include fever, 
fatigue, insomnia, joint pain, headache, weight loss, cardiac 
arrhythmias, and muscle pain (16). The major risk factors for B. 
quintana include infections, precarious conditions and chronic 
alcoholism. These risk factors are the same as those found 
for human immunodeficiency virus (HIV) and endocarditis 
(17). Therefore, although endocarditis caused by Bartonella 
spp has been underestimated, the presence of Bartonella 
infection should be further investigated in patients with nega-
tive blood culture and epidemiological antecedents related to 
chronic alcoholism, precarious conditions, contact with cats, 
fleas and lice, and in patients with endocarditis and positive 
serology for Chlamydia sp (18). B. quintana, B. henselae and 
B. elizabethae were first described as the causal agents of 
endocarditis in humans. Two other subspecies of B. vinsonii, 
berkhoffii and arupensis, were later found to be associated with 
endocarditis in patients with existing valvulopathies (14,18). 
B. henselae, which leads to endocarditis in children, exhibits 
negative results in serological tests (19). A number of studies in 
European countries have recently demonstrated that Coxiella 
burnetii, B. henselae and B. quintana are significantly associ-
ated with endocarditis in patients with negative blood culture 
(20). Siciliano et al. (21) showed that, of 61 assessed patients 
with endocarditis, 17 (27%) still had negative blood cultures. We 
reason that there are many negative blood cultures because 
the bacteria grow slowly and only in enriched medium (usually 
colonies are seen only after 20 days), which are conditions not 
routinely used in diagnostic laboratories. Serological tests are 
still helpful for diagnosis, but serum cross-reactivity between 
Bartonella, Chlamydia, and Coxiella species may interfere with 
the diagnosis and choice of treatment (6,20). Thus, molecular 
techniques such as PCR may be critical in providing a faster and 
more specific diagnosis of the disease (15,22). More recently, 
a multiplex PCR assay was developed to detect more than 20 
different known and some unknown Bartonella species in both 
clinical and environmental samples (23). The gene targets 
for PCR amplification for the identification of specific species 
of Bartonella are either the conserved 16S rRNA, a generic 
marker for detecting any Bartonella species, or the intergenic 
transcribed spacer 16S-23S rRNA (23).
The medical significance of Bartonella species as human 
pathogens has been demonstrated by epidemiological, natural 
history, pathological, and host-microbial interaction studies 
(11,24). Patient co-infection by B. henselae and Borrelia 
burgdorferi has also been described (25) and therefore the 
association of Bartonella spp with other zoonoses must be 
investigated. Chagas disease is an important zooparasitosis 
in South America that frequently evolves to cardiomyopathy 
(26). To gain a better understanding of the consequences of 
Bartonella infection, we have analyzed samples from Brazilian 
and Argentinean patients with a single-step PCR assay. The 
subjects of this study, classified as heart disease patients, 
presented negative blood-culture endocarditis, relevant ar-
rhythmias or Chagas cardiomyopathy. Our results suggest a 
strong association between the presence of Bartonella spp 
and these diseases. To the best of our knowledge this is the 
first report of such data from South America.
Material and Methods
Ethical aspects
The current project was approved by the Ethics Commit-
tee of Universidade Federal de São Carlos (UFSCar; CAAE 
#0024.1.135.000-06) and all subjects gave written informed 
consent to participate. 
Patients and controls
This study investigated 56 normal voluntary subjects (con-
trol group) without cardiac disease and 148 voluntary subjects 
with heart diseases (46 cases with negative blood-culture 
endocarditis, 29 with relevant cardiac arrhythmias and 73 with 
chronic Chagas cardiomyopathy) between 2004-2008. These 
subjects were assessed and selected by cardiologists from 
Brazil and Argentina. Each subject was asked to complete a 
standard questionnaire, which included age, gender, previ-
ous contact with animals and arthropods, clinical symptoms, 
and eventual antibiotic treatment. The control group included 
32 volunteers from a medical course in the city of Paracatu, 
Minas Gerais State, and 24 from the city of São Carlos, in São 
Paulo State, Brazil. Among this last group, 10 were from a rest 
home for the elderly and did not present any detectable heart 
problems. The patients with arrythmia and endocarditis were 
from the cities of São Carlos (SP, 10 cases) and from the city 
of São Paulo (SP, 65 cases). Fifty-two cases of Chagas cardio-
myopathy were selected from the University Hospital, Ribeirão 
Preto (SP), Brazil. Twenty-one patients with chronic Chagas 
cardiomyopathy from Argentina were selected from the locality 
of Añatuya, Santiago del Estero, a highly endemic region in 
Argentina. Thirty-two asymptomatic subjects but seropositive 
for Chagas disease were selected from blood donors admitted 
to Hemocentro Buenos Aires and to the service of Obstetrics 
of Rivadavia Hospital. All of them were residents of the metro-
politan area of Buenos Aires but 6 were originally from Bolivia, 
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3 from Paraguay, and 6 from the Chaco region (26). 
Blood sample collection from the subjects
A 10-mL sample of venous blood was collected into vacuum 
tubes containing 72 USP units of EDTA/tube that was used 
for extraction of genomic DNA. DNA was extracted from 500 
µL total blood according to modifications of the methodology 
described by Lahiri and Nurnberg Jr. (27). Alternatively, 10 mL 
peripheral blood was collected from Chagas disease patients 
and immediately mixed with one volume of 2X lysis buffer 
containing 6 M guanidinium hydrochloride and 0.2 M EDTA, 
pH 8.0 (GE) (28). The GE-blood lysate (GEB) was boiled (29) 
and stored at 4oC. DNA was purified from 100 µL aliquots of 
GEB by phenol extraction and isopropanol precipitation, as 
previously reported (30).
DNA amplification 
Genomic DNA from blood was used as template for PCR to 
confirm the presence of Bartonella spp. The primers used in the 
PCR were designed as previously described (7). The primer se-
quences were Bh16SF (5’-AGAGTTTGATCCTGGCTCAG-3’) 
and Bh16SR (5’-CCGATAAATCTTTCTCCCTAA-3’), which 
amplify a 185-bp fragment of the 16S rRNA gene of B. henselae 
strain Houston-1 (GenBank accession No. NC_005956). The 
primers P1-5EZ (5’-ATAATCACATGGAGAGCCACAAGCT-3’) 
and P2-3EZ (5’-GCACTTCTTTGGTATCTGAGAAAGT-3’), 
which amplify a 447-bp product of the ZFY and ZFX human 
genes, were used to assess the DNA integrity of the extracted 
blood samples (31). Each reaction contained 1 µg DNA, 0.2 
µg of each primer, 250 µM of each dNTP, 10 mM Tris-HCl, pH 
8.5, 25 mM KCl, 5 mM (NH4)2SO4, 2 mM MgCl2, and 1.5 U 
Taq DNA polymerase in a final volume of 100 µL. 
The PCR conditions were as follows: 35 cycles of 95°C for 
30 s, 54°C for 1 min, and 
72°C for 45 s, followed by 
a final extension of 10 min 
at 72°C. The amplification 
products were analyzed 
on 1.5% agarose gels in 
the presence of ethidium 
bromide. A negative con-
trol was included in each 
PCR run to avoid false 
results. Bands from rep-
resentative samples cor-
responding to the 185-bp 
fragment were removed 
from the agarose gels, 
purified using the Per-
fectprep Gel Cleanup Kit 
(Eppendorf, Germany) 
and sequenced. The 
samples were prepared 
using the DYEnamic™ 
ET Dye Terminator Kit 
(GE Healthcare®, Sweden) with the same primers. The reac-
tions were cycled (95°C for 20 s, 50°C for 15 s, and 60°C for 
1 min), precipitated using ammonium acetate and ethanol, 
washed with 70% ethanol, eluted in 10 µL loading solution, 
and run on a MegaBACE™ DNA Analysis System (GE 
Healthcare®).
DNA data analysis
The sequences obtained were analyzed using the BLAST 
program (http://www.ncbi.nlm.nih.gov/BLAST/) (32) and com-
pared to each other with the MULTALIN program (http://prodes.
toulouse.inra.fr/multalin/multalin.html) (33).
Statistical analysis
The correlation between DNA amplification for Bartonella 
spp and human heart diseases was analyzed by the chi-square 
test. This test was used to determine if the observed frequency 
of heart disease associated with Bartonella bacteremia was 
significantly different from the distribution of expected heart dis-
ease frequency. In addition, the odds ratio was also calculated 
to measure the strength of association or non-independence 
between the two calculated frequencies (34).
Results
Study patients and controls
A total of 204 subjects were selected clinically and DNA 
samples were obtained from their blood (Table 1). The most 
important criteria for inclusion in the heart disease group were 
the presence of blood-negative endocarditis, relevant arrhyth-
mias or Chagas cardiomyopathy. Patients with endocarditis or 
arrhythmias were serum negative for Chagas disease. Most 
subjects reported to have had previous contact with animals 
Table 1. Distribution of the 204 subjects who participated in this study from April 2004 to June 2008.
Groups N/group City/Statea Age Gender Contact with 
animals
Brazil
Control group 32 Paracatu, MG 22.3 ± 4.0 15 M, 17 F ~50%
24 São Carlos, SP 47.2 ± 21.4  8 M, 16 F 100%
Case groups
Endocarditis 46 São Paulo, SP 53.5 ± 15.1 26 M, 20 F ~60%
Arrhythmias 19 São Paulo, SP NI 12 M, 7 F 100%
Arrhythmias 10 São Carlos, SP 61.8 ± 23.7  3 M, 7 F 100%
Chagas cardiomyopathy 52 Ribeirão Preto, SP 71.3 ± 12.9 36 M, 16 F NI
Argentina
Chagas cardiomyopathy 21 Buenos Aires 37.9 ± 6.9  9 M, 12 F NI
Chagas asymptomaticb 32 Buenos Aires 41.8 ± 8.7 16 M, 16 F NI
Data are reported as means ± SD. aPlace of blood donation. Four members of the endocarditis group 
were treated with nonspecific antibiotics before blood collection. bAsymptomatic Argentinean subjects 
(N = 32) were used only for comparison with Chagas disease patients and not included in the total. 
NI = not informed.
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(dogs, cats, and horses) but this was not an exclusive 
criterion since it was highly variable along their lifetime. 
The most frequent diagnoses in the endocarditis group 
were mitral insufficiency, aortic stenosis, mitral stenosis, 
and mitral dysfunction, among others. Four cases of en-
docarditis were treated with nonspecific antibiotics before 
blood collection. Data from a group of 32 asymptomatic 
Argentinean subjects but with positive serology for Chagas 
disease were also obtained and used only for comparison 
with Chagas disease patients. However, this group was 
not considered to be either a control or case group and 
therefore it was not included in the total. 
Amplification of human DNA samples 
Patient DNA was subjected to PCR with the described 
oligonucleotides and the products were analyzed on a 
1.5% agarose gel for the detection of 185- and 447-bp 
fragments. All reactions showed the positive control frag-
ment of 447 bp. The 185-bp fragment, corresponding to 
the 16S rRNA gene of Bartonella, was present in 1 (1.8%) 
subject from the control group and in 60 (40.5%) subjects 
from the group of patients (Table 2; Figure 1A and B). 
The odds ratio and calculated chi-square are shown in 
Table 3. The odds ratio test showed a strong association 
between all groups of patients and the presence of bac-
teria. The risk of the Brazilian and Argentinean patients 
being infected with Bartonella spp was 37 times higher 
compared to control.
Data were also analyzed by Brazilian subgroups of the 
diseases. In this case, the risk of Bartonella spp bacteremia 
was 21.7 times higher for patients with endocarditis, 47.1 
times higher for patients with arrhythmias, and 40.3 times 
higher for Chagas cardiomyopathy patients (Table 3). The 
risk of an Argentinean patient with Chagas cardiomyopathy 
to be infected with Bartonella was not significantly differ-
ent from that of a Brazilian patient with the same disease. 
No statistical difference was found between Argentinean 
asymptomatic subjects with positive serology and the group 
of Argentinean patients with Chagas cardiomyopathy.
DNA sequencing of PCR products
Representative sequences (N = 35) from each group 
obtained from the PCR products were compared to the 
sequences deposited in public databases and confirmed the 
presence of Bartonella spp in the subjects. Figure 2 shows 
an alignment of representative sequences from 10 different 
positive subjects. Only two substitutions were found for this 
group in the sequence spanning position +13 to +193 bp. 
The consensus sequence of this alignment was compared 
to bacterial sequences at GenBank with the highest hits 
(e-value of 9e-06) with the 16S ribosomal RNA from several 
Bartonella species (Table 4). The majority of sequenced 
samples showed greater similarity to B. henselae, but 
bacteremic subjects could be found with B. vinsonii, B. v. 
berkhoffii and B. quintana sequence similarity.
Discussion 
The incidence of negative blood-culture endocarditis 
cases ranges from 3 to 31% of all cases of endocarditis 
(20,35). Zoonoses and bacterial infections transmitted by 
arthropods are now recognized as emerging infectious 
agents that could cause endocarditis. In the present study, 
we analyzed 46 culture-negative endocarditis patients and 
Figure 1. Analysis of the products obtained by PCR amplifica-
tion of a fragment of the Bartonella spp 16S rRNA gene from 
DNA extracted from whole blood of humans with endocarditis (A) 
and subjects from the control group (B). Lane 1 = Ladder 1-kb 
marker; lanes 2 to 6 = PCR products in representative samples 
from 5 individuals. The 185- and 447-bp fragments (lower and 
upper bands) refer to the amplification of bacterial 16S rRNA and 
control gene, respectively. 
Table 2. Amplification of 16S rRNA for the detection of Bartonella 
spp in healthy volunteers (controls) and patients with heart dis-
eases from Brazil and Argentina.
Group Number of samples* Positive PCR 
(16S rRNA)
Negative PCR 
(16S rRNA)
Controls  56 1 (1.8%)  55 (98.2%)
Cases# 148 60 (40.5%)  88 (59.5%)
Total 204 61 (29.9%) 143 (70.1%)
*Samples from the two countries. #Asymptomatic subjects from 
Argentina were not included.
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found that 13 (28%) were positive for Bartonella spp. These 
results are consistent with previous data, which suggest 
that Bartonella infection is observed in 28 to 50% of all 
culture-negative endocarditis cases (20,35). Bartonella 
infection is probably underdiagnosed due to nonspecific 
symptoms such as fever, weight loss and muscle pain. 
However, symptoms may become progressively more se-
vere with eventual neurological symptoms if patients are not 
treated (11). Embolic phenomena and glomerulonephritis 
have also been described as complications of Bartonella 
infection (18,20). Serology has been shown to be useful 
in confirming the presence of C. burnetii and Bartonella 
species, but the PCR technique proved to be more sensi-
tive and specific for the diagnosis of specimens such as 
Tropheryma whipplei, Bartonella and fungi in blood and 
valvular biopsies (36). 
There are few reports on the association of Bartonella 
and cardiac malignant arrhythmias in dogs (7) or humans (8). 
It was suggested that Bartonella spp induced silent subacute 
myocarditis and electric instability, which could be the major 
Figure 2. Alignment of 10 representative sequences of amplified fragments from patients infected with Bartonella. The alignment 
shows the high identity between the sequences. The consensus sequence was blasted against the GenBank collection with signifi-
cant hits (e-value of 9e-06) with 16S ribosomal RNA from different Bartonella species (accession Nos. of the best hits: DQ645425.1, 
DQ228135.1, U26258.1, M11927, AF143446.1, DQ641913.1).
Table 3. Association of heart disease and the presence of bacteria in the blood of patients.
Groups No. of subjects Positive PCR Negative PCR OR 95%CI P
Without heart disease, total 56 1 55    
Heart disease, total 148 60 88 37.50 5.4-748.7 <0.001*
Chagas disease, total 73 34 39 47.95 6.5-981.0 <0.001*
Brazilian subjects
Controls 56 1 55
Endocarditis 46 13 33 21.67 2.7-463.8 <0.001*
Arrhythmias 29 13 16 44.69 5.3-986.2 <0.001*
Chagas cardiomyopathy 52 22 30 40.33 5.3-842.8 <0.001*
Argentinean subjects
Chagas cardiomyopathy 21 12 9
Chagas asymptomatic 32 11 21 2.55 0.71-9.28 0.17#
Chagas cardiomyopathy
Brazilian patients 52 22 30
Argentinean patients 21 12 9 0.55 0.17-1.72 0.37##
OR = odds ratio; CI = confidence interval. *Compared to control. #Compared to Argentinean subjects with Chagas 
cardiomyopathy; ##compared to Brazilian subjects with Chagas cardiomyopathy.
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pathogenic factor in the development of arrhythmogenic 
right ventricular cardiomyopathy-like disease. However, the 
association between Bartonella spp infection and the onset 
of arrhythmias is not yet well understood. In this study, we 
show that 13 of 29 patients (45%) with arrhythmias were 
also positive for Bartonella, suggesting a strong association 
between bacterial infection and the disease. 
Chagas disease (American trypanosomiasis) is still 
a major health concern in South America. According to 
the World Health Organization, 10 million people are in-
fected with Trypanosoma cruzi worldwide, mostly in Latin 
America (37). Up to 30% of chronically infected people 
develop cardiac disorders and up to 10% develop diges-
tive, neurological, or mixed alterations, for which specific 
treatment may become necessary. Here we demonstrate 
a strong association between Chagas cardiomyopathy 
and Bartonella infection in Brazilian and Argentinean pa-
tients. Also, there was no statistically significant difference 
between asymptomatic Argentinean subjects with posi-
tive serology and the group of Argentinean patients with 
Chagas cardiomyopathy. These results suggest a role for 
the vector of American trypanosomiasis, mostly Triatoma 
infestans, in transmitting Bartonella or other bacteria. This 
possibility should be investigated in order to achieve a 
better understanding of the association of Chagas disease 
and Bartonella bacteremia. The high prevalence of positive 
subjects in the Chagas disease group strongly suggests 
that a method for controlling this zoonosis is necessary. The 
contribution of Bartonella spp infection to the evolution of 
Chagas disease or to the intensity of symptoms remains 
to be determined. 
One in 56 asymptomatic subjects that donated blood 
for this study had Bartonella spp bacteremia. Asymptomatic 
bacteremia had been already reported in blood donors (38). 
Immunodeficient patients, as HIV seropositive patients or 
patients receiving corticotherapy, can have angioprolifera-
tive reactions as seen in bacillary angiomatosis or bacillary 
peliosis hepatic as well fatal Bartonella spp infection (39). 
Further studies will be necessary to establish the relevance 
of Bartonella spp transmission by transfusion, especially in 
immunodeficient patients.
Our data show that Bartonella spp may be important 
etiologic agents of culture-negative endocarditis and should 
be investigated in all culture-negative endocarditis cases 
as well as in other suspected conditions. Our results also 
suggest a strong association between Bartonella spp 
bacteremia and arrythmia or Chagas cardiomyopathy. As 
far as we know, this is the first report of such data from 
South America. 
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Table 4. Best BLAST results for the PCR product sequences of representative samples of each group.
Groups Retrieved 
BLAST number
Number of individuals with identical 
sequences within the same group
Species with the 
highest hit
Similarity 
(%)
Control (N = 10) DQ228135.1
DQ645425.1
U26258.1
M11927
4
3
2
1
B. vinsonii berkhofii 
B. henselae
B. vinsonii
B. quintana
99
99
99
97
Endocarditis (N = 9) DQ641913.1
AF143446.1
U26258.1
4
3
2
B. henselae
B. vinsonii berkhofii
B. vinsonii
99
99
98
Arrhythmia (N = 8) DQ645425.1
DQ641913.1
U26258.1
3
3
2
B. henselae
B. vinsonii berkhofii
B. vinsonii
99
99
98
Chagas disease (N = 8) DQ645425.1
DQ228135.1
U26258.1
4
2
2
B. henselae
B. vinsonii berkhofii
B. vinsonii
99
99
99
N = number of representative PCR products that were sequenced for each group. B. = Bartonella.
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